Envista Holdings Corporation Stock
Equities
NVST
US29415F1049
Medical Equipment, Supplies & Distribution
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
19.81 USD | +0.30% | -1.05% | -17.66% |
Financials (USD)
Sales 2024 * | 2.57B | Sales 2025 * | 2.67B | Capitalization | 3.4B |
---|---|---|---|---|---|
Net income 2024 * | 151M | Net income 2025 * | 210M | EV / Sales 2024 * | 1.52 x |
Net Debt 2024 * | 494M | Net Debt 2025 * | 47.01M | EV / Sales 2025 * | 1.29 x |
P/E ratio 2024 * |
22.5
x | P/E ratio 2025 * |
16.5
x | Employees | 12,800 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 98.48% |
Latest transcript on Envista Holdings Corporation
1 day | +0.30% | ||
1 week | -1.05% | ||
Current month | +0.66% | ||
1 month | -2.56% | ||
3 months | -16.62% | ||
6 months | -6.78% | ||
Current year | -17.66% |
Managers | Title | Age | Since |
---|---|---|---|
Stephen Keller
DFI | Director of Finance/CFO | 49 | 18-12-31 |
Andrew Chen
CTO | Chief Tech/Sci/R&D Officer | - | - |
Suraj Satpathy
HRO | Human Resources Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 65 | 19-08-31 | |
Daniel Raskas
BRD | Director/Board Member | 57 | 18-12-31 |
Vivek Jain
BRD | Director/Board Member | 52 | 20-04-06 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.75% | 8 M€ | -.--% | ||
0.69% | 2 M€ | +6.77% | ||
0.34% | 509 M€ | -.--% |
Date | Price | Change | Volume |
---|---|---|---|
24-05-02 | 19.81 | +0.30% | 4,715,517 |
24-05-01 | 19.75 | +0.36% | 2,509,131 |
24-04-30 | 19.68 | -4.56% | 2,775,266 |
24-04-29 | 20.62 | +1.13% | 1,411,750 |
24-04-26 | 20.39 | +1.85% | 1,816,943 |
Delayed Quote Nyse, May 02, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-17.66% | 3.4B | |
-3.77% | 184B | |
-1.77% | 107B | |
-1.43% | 69.44B | |
+2.06% | 50.37B | |
+9.43% | 44.82B | |
+3.40% | 41.53B | |
+3.04% | 26.73B | |
+4.64% | 26.84B | |
+15.23% | 25.71B |
- Stock Market
- Equities
- NVST Stock